Berman Howard
SEC insider (Form 3/4/5 filer). CIK 0001952986. Director at Atea Pharmaceuticals, Inc. (AVIR) and 1 other issuer. 5 reported Form 4/5 transactions since Sep 2024; latest on Jun 18, 2026. Located in BOSTON, MA.
Companies Berman Howard has filed insider reports for
- Atea Pharmaceuticals, Inc. (AVIR): Director
- Coya Therapeutics, Inc. (COYA): Director, Officer, Executive Chairman
Berman Howard
CIK: 0001952986
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jun 18, 2026AVIR
Atea Pharmaceuticals, Inc.
AwardDirectRestricted Stock Units
26.7K shares- - Jun 18, 2026AVIR
Atea Pharmaceuticals, Inc.
AwardDirectStock Option (Right to Buy)
37.7K shares- - Jan 22, 2026COYA
Coya Therapeutics, Inc.
AwardDirectStock Option (right to buy)
15.3K shares- - Jun 20, 2025AVIR
Atea Pharmaceuticals, Inc.
AwardDirectStock Option (Right to Buy)
164.8K shares- - Jan 9, 2025COYA
Coya Therapeutics, Inc.
AwardDirectStock Option (right to buy)
150.6K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 18, 2026 |  AVIR Atea Pharmaceuticals, Inc. | Award Restricted Stock Units | 26,700 | - | - | Direct |
| Jun 18, 2026 | AVIR Atea Pharmaceuticals, Inc. | Award Stock Option (Right to Buy) | 37,700 | - | - | Direct |
| Jan 22, 2026 |  COYA Coya Therapeutics, Inc. | Award Stock Option (right to buy) | 15,257 | - | - | Direct |
| Jun 20, 2025 | AVIR Atea Pharmaceuticals, Inc. | Award Stock Option (Right to Buy) | 164,800 | - | - | Direct |
| Jan 9, 2025 | COYA Coya Therapeutics, Inc. | Award Stock Option (right to buy) | 150,602 | - | - | Direct |
1-5 of 5 transactions